Akamis Bio (Venture)
Funding Details
Awarder
Inbox
Date Award
December 17, 2024
Vertical
Oncology
Funding Amount
$60,000,000
Company Info
Organizations Involved
Merck, Cancer Research Institute
Founders
Howard Davis, PhD
Market
Immunotherapy for solid tumors
Location
Cambridge, MA, USA
Coinvestors
Sedgwick Yard
Company Description

Akamis Bio is a clinical-stage oncology company.